EmblemHealth Files Class Action Antitrust Against Alexion Related to Eculizumab
UK’s MHRA Grants Marketing Authorization for Chikungunya Vaccine
EMA’s CHMP Recommends Approval of Six New Biosimilars
FDA approves CAR-T Cell Therapy for Refractory B-cell Precursor Acute Lymphoblastic Leukemia
Amgen Files BPCIA Complaint Against Fresenius Kabi Regarding Denosumab
The Centers for Medicare & Medicaid Services Announces Lower Prices for First Ten Drugs Selected for Medicare Price Negotiation
FDA Issues Draft Guidance on Postapproval Manufacturing Changes to Biosimilar Products
Eculizumab BPCIA Litigation Update: Court Denies Alexion’s Motion for an Injunction Pending Appeal
Fresenius Kabi Announces Launch of TYENNE, a Tocilizumab Biosimilar Referencing ACTEMRA
Subscribe: Subscribe via RSS
Blogs
Firm/Org